Owlet, Inc. (OWLT) - Q2 2024 10-Q Summary
Business Context and Reporting Period
This Quarterly Report on Form 10-Q covers the period ended June 30, 2024. Owlet, Inc. is a digital parenting platform company that designs, develops, and sells smart baby monitoring products, including the Smart Sock, Dream Sock, and Owlet Cam. The company is classified as a smaller reporting company and an emerging growth company. All share and per-share data have been retrospectively adjusted for a 1-for-14 reverse stock split effective July 7, 2023.
Key Financial Metrics
| Metric (in thousands) | Q2 2024 | Q2 2023 | YTD 2024 | YTD 2023 |
|---|---|---|---|---|
| Revenues | $20,699 | $13,088 | $35,449 | $23,824 |
| Gross Profit | $10,252 | $5,233 | $16,799 | $9,386 |
| Gross Margin | 49.5% | 40.0% | 47.4% | 39.4% |
| Operating Loss | $(2,244) | $(6,714) | $(7,990) | $(17,670) |
| Net Income (Loss) | $(1,147) | $(8,467) | $2,127 | $(20,334) |
| Net Loss Attributable to Common Stockholders | $(2,682) | $(9,793) | $(736) | $(22,313) |
| Cash and Cash Equivalents | $15,363 | $24,746 | $15,363 | $24,746 |
| Line of Credit Outstanding | $9,738 | $9,250 | $9,738 | $9,250 |
| Term Loan Outstanding | $2,000 | $5,000 | $2,000 | $5,000 |
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 58.2% year-over-year for Q2 2024, driven by higher sales of Owlet Sock products and increased consumer demand across all channels.
- Margin Expansion: Gross margin improved significantly from 40.0% to 49.5% in Q2 2024 due to higher revenue volume and lower direct product and fulfillment costs.
- Operating Expenses: General and administrative expenses decreased 17.7% year-over-year for the six-month period due to reduced consulting and transaction costs. Research and development expenses decreased 16.6% due to prior restructuring actions.
- Non-Operating Gains: The company recognized a $10.2 million gain from the adjustment of common stock warrant liabilities for the six months ended June 30, 2024, compared to a $0.3 million gain in the prior year. This gain was the primary driver of the net income for the six-month period.
- Liquidity: Cash and cash equivalents decreased to $15.4 million from $16.6 million at year-end 2023. Net cash used in operating activities improved to $6.7 million (YTD 2024) from $16.8 million (YTD 2023).
Guidance, Outlook, Risks, and Contingencies
Going Concern Warning: The company has disclosed substantial doubt about its ability to continue as a going concern within one year. This is due to recurring operating losses, negative cash flows from operations, and a low cash balance relative to current obligations. Management is addressing this through recent preferred stock offerings and debt amendments.
Financing Activities:
- Preferred Stock: In February 2024, the company raised $9.25 million via a Series B convertible preferred stock offering.
- Debt Amendments: The company amended its Loan and Security Agreement with Silicon Valley Bank (SVB) to defer the maturity of its revolving line of credit to December 31, 2024, and waived certain covenant violations.
Legal Proceedings: The company is defending against two consolidated putative class action lawsuits (Butala and Cherian) alleging securities violations related to FDA classification of the Smart Sock. On August 5, 2024, the court denied the company's motions to dismiss these claims.
Regulatory Risks: The company faces ongoing regulatory scrutiny regarding the classification of its products (Smart Sock and Dream Sock) as medical devices in various international jurisdictions (e.g., Canada, EU, UK). Failure to obtain necessary authorizations could result in sales bans or recalls.
Internal Controls: The company identified material weaknesses in internal control over financial reporting, including deficiencies in the control environment, segregation of duties, inventory accounting, and IT general controls. Disclosure controls and procedures were deemed ineffective as of June 30, 2024.
Key Facts for Investor Verification
- Cash Runway: Verify the sufficiency of the $15.4 million cash balance against the $9.7 million outstanding line of credit and $2.0 million term loan maturing in October 2024.
- Warrant Liability Volatility: Note that net income for the six months ended June 30, 2024, was driven largely by a non-cash $10.2 million gain from warrant liability adjustments, not core operations.
- Regulatory Status: Monitor the status of FDA and international regulatory approvals for the Smart Sock and Dream Sock, as enforcement actions could halt revenue streams.
- Internal Control Remediation: Assess the progress of the remediation plan for material weaknesses in financial reporting, which poses a risk to the accuracy of future filings.
- NYSE Listing Compliance: Verify the company's progress in meeting NYSE continued listing requirements, specifically regarding market capitalization and stockholders' equity, to avoid delisting.